Silvia Pesci has a degree in Chemistry and a doctorate in Chemical Sciences from University of Rome ‘La Sapienza’. After obtaining her doctorate, she joined Merck Sharp & Dohme Group, working at the Istituto di Ricerche di Biologia Molecolare P. Angeletti (IRBM) for fourteen years. Her main responsibilities, as a Research Biophysicist, included the structural elucidation of lead compounds and the identification of key properties related to potency and pharmacokinetics, supporting the Drug Discovery and Preclinical Development programs of the Medicinal Chemistry and Pharmacology Departments.
Dr. Pesci joined Donawa Lifescience Consulting (DLC) in 2010, after obtaining a masters degree in ‘Sviluppo Preclinico e clinico del Farmaco’ from Università Cattolica del Sacro Cuore, Roma. Her main responsibilities at DLC include helping clients with ethics committee and competent authority clinical study submissions and supporting the clinical monitoring and regulatory functions of the company.